Investors Flock to Nebius as Artificial Intelligence Purchase Sparks Double-Digit Price Uptick

Table of Contents Nebius Group (NBIS) experienced a significant rally on Friday, soaring 11.8% with shares touching $156.00 during the session before closing at $154.49. Trading volume reached approximately 15.7 million shares, modestly exceeding typical daily activity. Nebius Group N.V., NBIS The primary driver behind the surge was the company’s announcement of its intent to acquire Eigen AI in a transaction valued at roughly $643 million, structured as a combination of cash and stock. Eigen AI specializes in inference technology and post-training optimization solutions. Nebius intends to integrate these advanced capabilities into its existing Nebius Token Factory platform, which is designed to handle production-scale AI workloads. The transaction is anticipated to reach completion within the next few weeks, subject to customary closing conditions including regulatory approvals from antitrust authorities. Beyond technology integration, Nebius emphasized that this acquisition will significantly expand its presence in the United States. The founding team from Eigen AI is expected to establish and lead an engineering and research hub in the San Francisco Bay Area. The stock rally was further amplified by heightened options trading activity. Market participants purchased approximately 130,000 call option contracts during Friday’s session — roughly 23% above the typical volume — indicating strong speculative positioning ahead of upcoming company events. A broader market uplift in the technology sector also contributed to the gains. AI-focused companies and cloud infrastructure stocks posted widespread advances on Friday as the Nasdaq Composite registered solid gains. Analyst opinion on NBIS remains cautiously optimistic overall. The consensus recommendation stands at “Moderate Buy” with a mean price target of $154.75, virtually identical to Friday’s closing price. DA Davidson represents the most optimistic view with a price target of $200.00, while Morgan Stanley takes a more conservative stance with an “equal weight” rating and a $126.00 price objective. Bank of America and Compass Point both maintain “buy” recommendations with $150.00 targets. Recent insider activity shows two senior executives sold shares in mid-April. Director Elena Bunina disposed of 6,250 shares at $161.22 per share, and Chief Revenue Officer Marc Boroditsky sold 4,500 shares at $160.10. Both transactions were conducted through pre-established 10b5-1 trading plans. Collectively, company insiders have sold approximately 129,740 shares valued at more than $14.6 million over the past three months. From a financial performance standpoint, Nebius continues to face challenges. The company fell short of earnings per share projections in its most recent quarterly report, recording a loss of $0.69 per share compared to the consensus estimate of -$0.42. Revenue totaled $227.7 million, missing analyst expectations of $246 million. The stock currently trades with a price-to-earnings ratio of -105.82 and exhibits a beta of 4.20, underscoring its high-volatility, high-risk investment profile. Analysts project a full-year loss of $2.44 per share. Technically, the stock is trading well above its moving averages. The 50-day moving average stands at $120.73 and the 200-day at $106.24, meaning Friday’s closing price represents a significant premium to both trend indicators. Institutional investors collectively hold approximately 21.9% of outstanding NBIS shares. Investors will receive the next update on May 13 when the company releases its Q1 2026 results before the market opens.